Metabolic complications of aggressive therapy of chronic lymphocytic leukemia.
D000818:Animals; D001772:Blood Cell Count; D001792:Blood Platelets; D001806:Blood Urea Nitrogen; D002118:Calcium / Q000097:blood; D002699:Chlorambucil / Q000009:adverse effects / Q000627:therapeutic use; D003404:Creatinine / Q000378:metabolism; D004231:Diuresis; D004359:Drug Therapy, Combination / Q000009:adverse effects*; D006400:Hematocrit; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D006996:Hypocalcemia / Q000139:chemically induced; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D007958:Leukocyte Count; D008214:Lymphocytes; D008297:Male; D010710:Phosphates / Q000097:blood; D011188:Potassium / Q000097:blood; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D014511:Uremia / Q000139:chemically induced; D014527:Uric Acid / Q000097:blood
D010710:Phosphates; D002699:Chlorambucil; D014527:Uric Acid; D003404:Creatinine; D011188:Potassium; D002118:Calcium; D011241:Prednisone